These cardiovascular benefits become particularly important for people with obesity, who face elevated risks of heart disease, stroke and other cardiovascular complications
Appeals generate different justifications
The review evaluated whether a specific time to pause the use of a GLP-1 or dual GIP/GLP-1 RAs prior to anaesthesia could be recommended
For most patients starting GLP-1 treatment for weight management, semaglutide (either Wegovy or compounded) is a common first choice because it has the longest track record, the most clinical data, and the widest availability
During the call, your provider will discuss your weight loss history, medical conditions, medications, and goals, then determine your eligibility and recommended compound and starting dose
How Do GLP1 Medications Impact Heart Health